Quest Diagnostics is pleased to announce the acquisition of Pathway Diagnostics, a specialized provider of biomarker assay development, validation, and testing services. The extensive biomarker offering of Pathways Diagnostics, supported by Quest Diagnostics global network of standardized clinical trials central laboratories, brings value to pharmaceutical companies looking to incorporate novel biomarkers into their clinical study protocols.

ASK US HOW.